Rabbit Recombinant Monoclonal PPP6C/Ppv antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 5 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
WB | IHC-P | ICC/IF | Flow Cyt (Intra) | |
---|---|---|---|---|
Human | Tested | Not recommended | Tested | Tested |
Mouse | Expected | Not recommended | Predicted | Predicted |
Rat | Expected | Not recommended | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100 - 1/250 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/280 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Select an associated product type
Catalytic subunit of protein phosphatase 6 (PP6) (PubMed:17079228, PubMed:29053956, PubMed:32474700). PP6 is a component of a signaling pathway regulating cell cycle progression in response to IL2 receptor stimulation (PubMed:10227379). N-terminal domain restricts G1 to S phase progression in cancer cells, in part through control of cyclin D1 (PubMed:17568194). During mitosis, regulates spindle positioning (PubMed:27335426). Down-regulates MAP3K7 kinase activation of the IL1 signaling pathway by dephosphorylation of MAP3K7 (PubMed:17079228). Participates also in the innate immune defense against viruses by desphosphorylating RIGI, an essential step that triggers RIGI-mediated signaling activation (PubMed:29053956). Also regulates innate immunity by acting as a negative regulator of the cGAS-STING pathway: mediates dephosphorylation and inactivation of CGAS and STING1 (PubMed:32474700, PubMed:32753499). CGAS dephosphorylation at 'Ser-435' impairs its ability to bind GTP, thereby inactivating it (PubMed:32474700).
PPP6, PPP6C, Serine/threonine-protein phosphatase 6 catalytic subunit, PP6C
Rabbit Recombinant Monoclonal PPP6C/Ppv antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 5 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
PPP6C also known as Protein Phosphatase 6 Catalytic Subunit is a protein phosphatase which participates in dephosphorylation processes. It has a molecular mass of approximately 35 kDa. PPP6C locates mainly in the cytoplasm but has also been found in the nucleus. Its expression is widespread across various tissues including the brain heart and skeletal muscle. PPP6C is important in controlling cellular functions by removing phosphate groups from target molecules influencing their activity state.
The protein influences cell cycle regulation cell proliferation and apoptosis. This protein typically functions as part of a larger enzymatic complex that includes regulatory and scaffold subunits. By associating with these proteins PPP6C gains specificity towards its substrates and ensures precise cellular responses. Its activity helps maintain cellular homeostasis and proper cell growth and it also modulates immune response pathways by controlling phosphatase activity which is especially critical for immune system functioning.
PPP6C interacts with key cellular signaling pathways such as the NF-kB and AKT pathways. During the regulation of these pathways PPP6C associates with proteins like IKK and PDK1 respectively which are important in mediating responses to external stimuli and regulating cell survival. Inhibition or dysregulation of PPP6C can impact these pathways leading to aberrant signaling and altered cellular outcomes. PPP6C's influence on these pathways highlights its role in fine-tuning cellular responses to diverse signals.
PPP6C has connections to melanoma and multiple myeloma. Mutations affecting PPP6C may lead to abnormal protein function contributing to the development of these cancers. For example in melanoma alterations in PPP6C can disrupt cellular signaling pathways often in coordination with related proteins like BRAF and NRAS. Understanding these interactions and their effects on disease progression can provide insights into cancer therapeutics and the development of targeted treatments.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-PPP6C/Ppv antibody [EPR8764] (ab131335) at 1/1000 dilution
Lane 1: HeLa cell lysate at 10 µg
Lane 2: Fetal thymus tissue lysate at 10 µg
Lane 3: 293T cell lysate at 10 µg
Lane 4: Jurkat cell lysate at 10 µg
All lanes: Goat anti-rabbit HRP conjugated at 1/2000 dilution
Predicted band size: 35 kDa
Immunofluorescent analysis of HeLa cells labelling PPP6C/Ppv with ab131335 at 1/100 dilution.
Intracellular Flow Cytometry analysis ofHeLa cells labelling PPP6C/Ppv with purified ab131335 at a dilution of 1/280 (red). Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. An Alexa Flour® 488-conjugated goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody.
Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com